The directed selection of recombinant human anti-testosterone antibodies and their use in immuno-modulating androgen receptor function
Prostate cancer (PCa) is the second most common cancer in Western men; with over 30,000 new cases are diagnosed in the UK each year. Primarily treatment involves targeting the androgen-signalling pathway by blocking production of testicular androgens and/or inhibiting AR function. Current treatments...
| Main Author: | |
|---|---|
| Published: |
University of Aberdeen
2007
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.493587 |